Tourmaline Bio Inc (TRML)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2024 | 12-2023 | 09-2023 | 06-2023 | 03-2023 | |
| Operating Expenses | 17,517 | 14,890 | 6,643 | 16,374 | 7,502 |
| Operating Income | -17,517 | -14,890 | -6,643 | -16,374 | -7,502 |
| Other Income | 4,206 | 1,988 | 1,052 | 245 | 0 |
| Pre-tax Income | -13,311 | -12,902 | -5,591 | -16,129 | -7,502 |
| Net Income Continuous | -13,311 | -12,902 | -5,591 | -16,129 | -7,502 |
| Net Income | $-13,311 | $-12,902 | $-5,591 | $-16,129 | $-7,502 |
| EPS Basic Total Ops | -0.55 | 20.86 | -5.16 | -16.29 | -8.28 |
| EPS Basic Continuous Ops | -0.55 | 20.86 | -5.16 | -16.29 | -8.28 |
| EPS Diluted Total Ops | -0.55 | 20.86 | -5.16 | -16.29 | -8.28 |
| EPS Diluted Continuous Ops | -0.55 | 20.86 | -5.16 | -16.29 | -8.28 |
| EPS Diluted Before Non-Recurring Items | -0.55 | -0.81 | -1.64 | N/A | N/A |
| EBITDA(a) | $-18,688 | $-15,401 | $-6,634 | $-16,367 | $-7,496 |